BioHarvest Sciences Inc. announced a non-brokered private placement of convertible notes for the gross proceeds of CAD 12,000,000 on October 19, 2023. The notes will have a term of 24 months, and pay interest of 12% per annum. The convertible notes and accrued interest will be convertible at the option of the holder into common shares of the Issuer at a conversion price that is equal to the closing market price of the company?s common shares on the date of conversion less a discount of 20% but in any event, not less than CAD 0.24 per share or more than CAD 0.75 per share.